[ASAP] Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.8b00136

Source: Journal of Medicinal Chemistry - March 9, 2018 Category: Chemistry Authors: Xiaoyang Li, Yuri K. Peterson, Elizabeth S. Inks, Richard A. Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong, C. James Chou Source Type: research